QuestCap Enters Binding Agreement to Acquire 28% Interest in Colombian Full-Service Medical Clinic

TORONTO, July 09, 2020 (GLOBE NEWSWIRE) — Social-impact investment company QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) announced today that it has entered into an arm’s length binding letter agreement (the “Agreement”) with Latin-Canada Pharma Inc. (Canada) to acquire a 28% indirect equity interest in Sanaty IPS S.A.S. (“Sanaty”), a full-service medical clinic in…

QuestCap Closes Transaction to Acquire 30% Interest in Glenco Medical

TORONTO, June 25, 2020 (GLOBE NEWSWIRE) — Social-impact investment company QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) announced today that it has closed the transaction to acquire 30% of Glenco Medical Corp. (“Glenco Medical”), first announced on June 15, 2020. QuestCap issued a total of 12 million QuestCap common shares to 2451013 Ontario Inc., Dr.…

QuestCap and MTJR Partnership Signs Sales Agreement for 500,000 Antibody Tests

TORONTO, May 06, 2020 — QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) is pleased to announce the first commercial sales agreement received for antibody tests by commercial partner and distributor MTJR. QuestCap and MTJR have agreed to supply 500,000 PCL COVID-19 IgG/IgM Antibody tests to BioCorp Clinical Laboratory (“BioCorp”), a high-complexity laboratory based in…

QuestCap Appoints Renowned Surgeon Dr. Joseph Sugerman to its Team of Global Advisors

TORONTO, May 01, 2020 — QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) announced today that prominent L.A.-based surgeon Dr. Joseph Sugerman has joined the QuestCap Advisory Board. As a well-regarded otolaryngologist, Dr. Sugerman will contribute substantial medical expertise to the QuestCap team of global experts engaged to advise on QuestCap’s investments in specialized industries,…

QuestCap Appoints New CEO and Executive Chairman and Closes Financing for Purchase of COVID-19 Antibody Testing Kits

TORONTO, April 29, 2020 — QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) is pleased to announce the appointment of Doug Sommerville to the role of Chief Executive Officer and as a director for the Company, effective immediately. As a veteran leader in the North American medical, pharmaceutical and technology industries, Mr. Sommerville will bring…